MentionFox
Home › Grants › Biosensics LLC
Federal R&D award · SBIR Phase II

Biosensics LLC SBIR Phase II award

Before you do business with Biosensics LLC

MentionFox check on Biosensics LLC: no red flags found in 38 sources (checked 10 November 2026). mentionfox.com/c/grants/biosensics-uf1ag094587

Check Biosensics LLC before you do business Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Biosensics LLC?

Award UF1AG094587, starting 2025-09-01. Every figure below is from the federal award record.

Department of Health and Human Services, through National Institutes of Health, awarded Biosensics LLC of Newton, MA $5,174,076 under the SBIR program (Phase II), with work starting 2025-09-01 and running to 2029-08-31. It is one of 3 SBIR and STTR awards Biosensics LLC received in the last two years, $7,518,476 in all. Each figure links to the federal record.

The award

RecipientBiosensics LLC (Newton, MA)
Awarding agencyDepartment of Health and Human Services
Awarding officeNational Institutes of Health
PhasePhase II
Amount obligated$5,174,076
Period of performance starts2025-09-01
Period of performance ends2029-08-31
Award numberUF1AG094587 (grant, CFDA 93.866)
Assistance listing93.866, Aging Research
Signed2025-08-28
Recipient registry id (UEI)C9MRZK4B7K39

Want the whole picture on Biosensics LLC?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Biosensics LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Biosensics LLC covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    33 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

What it is for

Digital health technologies for monitoring motor function in progressive supranuclear palsy and dementia with lewy bodies - project summary progressive supranuclear palsy (psp) is a severe and rapidly progressive frontot

Funding actions on this award

DateActionModificationAmount
2025-08-28New000$5,174,076
Digital health technologies for monitoring motor function in progressive supranuclear palsy and dementia with lewy bodies - project summary progressive supranuclear palsy (psp) is a severe and rapidly progressive frontotemporal lobar degeneration (ftld) syndrome that lacks effective treatment and leads to a rapid onset of dementia, disability, and death. Dementia with lewy bodies (dlb) is the second most common type of neurodegenerative dementia after alzheimer’s disease. Both psp and dlb cause significant motor impairment, resulting in progressive loss of independence in activities of daily living, such as eating, dressing, and writing. There are no fda-approved treatments for ftld syndromes (including psp) or dlb. One of the key challenges in the development of new effective therapies for dlb syndromes is the lack of validated instruments and biomarkers to measure disease severity, disease progression, and the effect of therapeutic interventions. Since 2019, biosensics, massachusetts general hospital (mgh) and johns hopkins university (jhu) have partnered to develop a wearable-based remote monitoring solution for ftld syndromes. The solution uses pamsystm, a patented and validated pendant sensor for monitoring physical activity, posture, and walking parameters during activities of daily living. Through a direct Phase II SBIR award (R44AG080861) from the national institute on ...

From the federal award record.

Other SBIR and STTR awards to Biosensics LLC

StartsAgencyProgramAmountProject
2026-09-01Department of Health and Human ServicesSTTR Phase I$314,362Digital assessment of motor skills in infants and young boys with duchenne muscular dystro (record)
2025-09-01Department of Health and Human ServicesSBIR Phase II$2,030,038A wearable sensor platform for remote monitoring of motor impairment in huntingtons diseas (record)

Every other federal award to Biosensics LLC on record

The federal register lists 35 or more other awards to the same registry id (UEI C9MRZK4B7K39), $58,061,517 in all, from 3 agencies.

StartsAgencyAmountAward
2024-09-11National Institutes of Health$400,000FY24 SBIR Phase I topic no. 459 project title: An automated screening platform for early identification of ma (75N91024C00094)
2024-05-20National Institutes of Health$2,000,000Biosensics llc:1186749 [24-003492] (75N95024C00010)
2024-05-01Defense Health Agency$2,463,953A wearable sensor platform for remote monitoring of individuals on the frontotemporal dementia spectrum (HT94252410421)
2023-09-01National Institutes of Health$2,022,000Software platform for automatic, opportunistic screening of vertebral compression fractures - project summary (R44AG084327)
2023-07-15National Institutes of Health$2,991,402A multi-modal wearable sensor for early detection of cognitive decline and remote monitoring of cognitive-moto (R44AG084487)
2023-06-01National Institutes of Health$1,884,699Automatic, opportunistic surveillance of hip bone fragility in x-ray images - project summary / abstract appr (R44AG081031)
2022-09-30National Institutes of Health$3,533,026A multi-modal remote monitoring platform for frontotemporal lobar degeneration syndromes - project summary/abs (R44AG080861)
2022-09-23National Institutes of Health$325,000Topic 022 - technological development and validation of remote measures foruse in clinical trials in individua (75N95022C00040)
2022-09-15National Institutes of Health$2,488,546Wearable sensor and digital technologies for quantitative assessment and remote monitoring of symptoms in myas (R44NS122672)
2020-08-01National Institutes of Health$3,173,065Teleexergame: An interactive tele-rehabilitation platform for improving motor function in older adults with co (R44AG067909)
2020-06-15National Institutes of Health$2,960,344CARE4AD: A comprehensive care coordination and management platform for alzheimer disease and related dementias (R44AG066360)
2019-09-15National Institutes of Health$2,981,726Ctra software solution for fracture risk assessment of axial skeleton (R44AG065014)
2018-09-30National Institutes of Health$2,500,000Tele-cf: A practical platform for remote monitoring of cognitive frailty - abstract cognitive frailty (cf), th (R44AG061951)
2018-09-15National Institutes of Health$2,614,223A mobile tai chi platform for fall prevention in older adults (R42AG059491)
2018-09-01National Institutes of Health$4,349,984An innovative platform for objective monitoring of instrumental activities of daily living (R42AG060853)
2017-09-01National Institutes of Health$2,522,326Wearable sensors for quantitative assessment of motor impairment in huntington's disease (R44NS103648)
2017-08-11National Institutes of Health$1,487,638Portable ultrasound system for automated detection of abdominal free-fluid (R44GM123821)
2017-08-11National Institutes of Health$500,000Portable ultrasound system for automated detection of abdominal free-fluid (R43GM123821)
2016-09-20Department of the Army$149,998STTR phase 1 - a16a-014-0117 (W81XWH16C0152)
2016-04-01National Institutes of Health$1,188,866Fracture risk assessment software for skeletal metastasis (SB1AR069421)
2016-04-01National Institutes of Health$750,000Fracture risk assessment software for skeletal metastasis (R44AR069421)
2015-09-30National Institutes of Health$1,498,127A novel system to detect falls in real-life conditions (R44AG051374)
2015-09-08National Institutes of Health$4,649,277Wrist-worn sensors for tele-rehabilitation of the hemiparetic upper-extremity (R44HD084035)
2015-06-15National Institutes of Health$1,455,491Upper extremity frailty assessment tool (R44AG050338)
2014-09-22Department of Veterans Affairs$5,549Moltion device (VA24514P1487)
2014-01-06Department of the Army$149,932SBIR phase 1 dhp 13-009, erms # 13261007 proposal # h132-009-0050 (W81XWH14C0008)
2013-12-20Department of the Army$149,977JPC-5 SBIR phase 1 (W81XWH14C0024)
2013-09-19Tricare Management Activity$6,626One ambulatory gait analysis leg sys (HT940413MV551)
2013-05-08Department of the Army$149,982SBIR Phase I - proposal # h122-015-0012 (W81XWH13C0095)
2013-04-10National Institutes of Health$1,489,196Interactive telehealth and auto-biofeedback sensor system for individuals who use a wheelchair (R44AG059275)
Want the whole picture on Biosensics LLC?

Who runs it, who owns it, where the money comes from and what to watch for, every claim linked to its source.

Order Full Report on Biosensics LLC
Not ready to order?

Look up Biosensics LLC first. Finding the company and seeing how much is on record uses no credits.

Look up Biosensics LLC

Where this comes from

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs set aside part of federal research budgets for small companies. Agencies award them in phases: Phase I tests whether an idea is feasible, Phase II funds development, and Phase III is follow-on work paid for outside the set-aside. STTR awards also require a research institution as a partner.

Every figure on this page is taken from the award's own federal record, linked beside it, as it stood when the page was built: the recipient, its address, the awarding agency and office, the amount obligated so far, the dates and the description. Phase and program are shown as the award's own description states them. The amount can grow later if the agency adds funding to the same award.

On these startup lists

Healthcare and health tech startups Medical device and diagnostics startups

Cite this page

Permanent URL: https://mentionfox.com/grants/biosensics-uf1ag094587
Last updated 2026-11-10
Primary record: Federal award record
Biosensics LLC: $5,174,076 SBIR Phase II award from HHS (2025). MentionFox, 2026-11-10. https://mentionfox.com/grants/biosensics-uf1ag094587